About
Advancing Breast Cancer Precision Medicine
Core Pillars of the Heng Lab
- Multimodal Research: We integrate wet-lab, computational biology, and translational strategies to address clinically important problems that cannot be solved within a single field.
- A Global Network: We partner with world-class physicians and scientists across Harvard, USA, and international institutions.
- Equitable Medicine: Pioneering critical research in transgender cancer to ensure precision medicine serves all populations.
Recent Publications
- Associations of circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 with the expression of stromal fibroblast activation markers in benign breast tissue
- Oral contraceptive use and the expression of stromal markers in benign breast tissue
- Subtype-Specific Associations of Computational Stromal Tumor-Infiltrating Lymphocytes with Breast Cancer Outcomes
- African Green Monkey Cerebrospinal Fluid miRNome Captures Conserved miRNAs Relevant to Human Neurodegenerative Disease
- Associations of alcohol use with expression of stromal markers in benign breast biopsy samples.
- The miR-362-3p/BCLAF1 axis regulates cisplatin sensitivity and metastatic progression in triple-negative breast cancer
